Shanghai Pharmaceuticals Holding Co., Ltd. Sponsored ADR (SHPMY)
OTC
7.38
-0.09 (-1.15%)
Closed
Aug 21, 2026
Day's Range
7.387.38
52 wk Range
7.048.32
Financial Statements - SHPMY - Shanghai Pharmaceuticals Holding Co., Ltd. Sponsored ADR
Revenue
283.57B▲ 3.0%
Net Income
6.97B▲ 18.8%Net Margin 2.5%
EBITDA
15.62B▲ 23.3%
Free Cash Flow
3.82B▲ 11.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 283.57B | 275.25B | 260.29B | 231.98B | 215.82B | 191.90B |
| Cost of Goods | 253.16B | 244.61B | 228.96B | 201.49B | 187.28B | 165.18B |
| Gross Profit | 30.41B | 30.63B | 31.32B | 30.48B | 28.54B | 26.72B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 9.28B | 9.68B | 9.56B | 8.78B | 7.92B | 8.13B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 9.81B | 8.02B | 7.05B | 8.80B | 8.14B | 7.17B |
| Income Tax | 2.84B | 2.14B | 1.88B | 1.81B | 1.86B | 1.57B |
| Net Income | 6.97B | 5.87B | 5.16B | 6.99B | 6.27B | 5.60B |
| EPS Basic | 7.7 | 6.15 | 5.1 | 8.05 | 8.95 | 7.9 |
| EPS Diluted | 7.7 | 6.15 | 5.1 | 8.05 | 8.95 | 7.9 |
| Basic Shares Outstanding | 743.44M | 740.24M | 5.36B | 5.05B | 4.12B | 4.12B |
| Diluted Shares Outstanding | 743.44M | 740.24M | 5.36B | 5.05B | 4.12B | 4.12B |
| Ebit | 11.50B | 9.64B | 8.71B | 10.22B | 8.40B | 8.30B |
| Ebitda | 15.62B | 12.67B | 11.43B | 11.50B | 10.91B | 11.17B |
| Net Income Continuous Operations | 6.97B | 5.87B | 5.16B | 6.99B | 6.27B | 5.60B |
| Minority Interests | -1.24B | -1.31B | -1.39B | -1.37B | -1.18B | -1.10B |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
